383 related articles for article (PubMed ID: 23324379)
1. The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway.
Katagiri T; Tsukamoto S
Biol Chem; 2013 Jun; 394(6):703-14. PubMed ID: 23324379
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
[TBL] [Abstract][Full Text] [Related]
3. [BMP signaling and bone formation].
Katagiri T
Clin Calcium; 2012 Nov; 22(11):1677-83. PubMed ID: 23103811
[TBL] [Abstract][Full Text] [Related]
4. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA.
de la Peña LS; Billings PC; Fiori JL; Ahn J; Kaplan FS; Shore EM
J Bone Miner Res; 2005 Jul; 20(7):1168-76. PubMed ID: 15940369
[TBL] [Abstract][Full Text] [Related]
5. Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva.
Katagiri T; Tsukamoto S; Kuratani M
Bone; 2018 Apr; 109():241-250. PubMed ID: 28754575
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H.
Ohte S; Shin M; Sasanuma H; Yoneyama K; Akita M; Ikebuchi K; Jimi E; Maruki Y; Matsuoka M; Namba A; Tomoda H; Okazaki Y; Ohtake A; Oda H; Owan I; Yoda T; Furuya H; Kamizono J; Kitoh H; Nakashima Y; Susami T; Haga N; Komori T; Katagiri T
Biochem Biophys Res Commun; 2011 Apr; 407(1):213-8. PubMed ID: 21377447
[TBL] [Abstract][Full Text] [Related]
7. [The role of Smads and related transcription factors in the signal transduction of bone morphogenetic protein inducing bone formation].
Xu XL; Dai KR; Tang TT
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Sep; 17(5):359-62. PubMed ID: 14551929
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into BMP receptors: Specificity, activation and inhibition.
Yadin D; Knaus P; Mueller TD
Cytokine Growth Factor Rev; 2016 Feb; 27():13-34. PubMed ID: 26690041
[TBL] [Abstract][Full Text] [Related]
9. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
10. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P
J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein receptor signal transduction in human disease.
Gomez-Puerto MC; Iyengar PV; García de Vinuesa A; Ten Dijke P; Sanchez-Duffhues G
J Pathol; 2019 Jan; 247(1):9-20. PubMed ID: 30246251
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP).
Billings PC; Fiori JL; Bentwood JL; O'Connell MP; Jiao X; Nussbaum B; Caron RJ; Shore EM; Kaplan FS
J Bone Miner Res; 2008 Mar; 23(3):305-13. PubMed ID: 17967130
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
Glister C; Kemp CF; Knight PG
Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
[TBL] [Abstract][Full Text] [Related]
14. BMP signaling in vascular diseases.
Cai J; Pardali E; Sánchez-Duffhues G; ten Dijke P
FEBS Lett; 2012 Jul; 586(14):1993-2002. PubMed ID: 22710160
[TBL] [Abstract][Full Text] [Related]
15. Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation.
Rosendahl A; Pardali E; Speletas M; Ten Dijke P; Heldin CH; Sideras P
Am J Respir Cell Mol Biol; 2002 Aug; 27(2):160-9. PubMed ID: 12151307
[TBL] [Abstract][Full Text] [Related]
16. BMP signaling in skeletal development.
Wan M; Cao X
Biochem Biophys Res Commun; 2005 Mar; 328(3):651-7. PubMed ID: 15694398
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.
Tanaka K; Inoue Y; Hendy GN; Canaff L; Katagiri T; Kitazawa R; Komori T; Sugimoto T; Seino S; Kaji H
Bone; 2012 Jul; 51(1):158-67. PubMed ID: 22579779
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K
Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a novel model of chondrogenesis using murine embryonic stem cells carrying fibrodysplasia ossificans progressiva-associated mutant ALK2.
Fujimoto M; Ohte S; Shin M; Yoneyama K; Osawa K; Miyamoto A; Tsukamoto S; Mizuta T; Kokabu S; Machiya A; Okuda A; Suda N; Katagiri T
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):347-52. PubMed ID: 25446088
[TBL] [Abstract][Full Text] [Related]
20. Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis.
Ahn J; Serrano de la Pena L; Shore EM; Kaplan FS
J Bone Joint Surg Am; 2003 Apr; 85(4):667-74. PubMed ID: 12672843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
